Harding Loevner LP Iqvia Holdings Inc. Transaction History

Harding Loevner LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$181.14 - $248.26 $6.84 Million - $9.37 Million	-37,745 Reduced 5.22%	684,784 $124 Million
Q2 2022 Aug 15, 2022	SELL	$196.45 - $252.29 $3.79 Million - $4.87 Million	-19,314 Reduced 2.6%	722,529 $157 Million
Q1 2022 May 16, 2022	SELL	$210.56 - $273.58 $10.2 Million - $13.3 Million	-48,661 Reduced 6.16%	741,843 $152 Million
Q4 2021 Feb 14, 2022	SELL	$238.37 - $282.61 $4.07 Million - $4.83 Million	-17,092 Reduced 2.12%	790,504 $223 Million
Q3 2021 Nov 15, 2021	SELL	$239.54 - $265.23 $6.56 Million - $7.27 Million	-27,394 Reduced 3.28%	807,596 $193 Million

Q2 2021 Aug 16, 2021	BUY	$198.06 - $246.77 $1.3 Million - $1.62 Million	6,580 Added 0.79%	834,990 $202 Million
Q1 2021 May 17, 2021	BUY	$173.0 - $194.59 $142 Million - $160 Million	823,490 Added 16737.6%	828,410 $160 Million
Q4 2020 Feb 16, 2021	BUY	$153.99 - $180.39 $742,231 - $869,479	4,820 Added 4820.0%	4,920 $882,000
Q4 2018 Feb 14, 2019	SELL	$105.7 - $130.35 $50,736 - $62,568	-480 Reduced 82.76%	100 $12,000
Q4 2017 Feb 12, 2018	BUY	$95.0 - $108.56 $55,100 - $62,964	580	580 $57,000

1,084

155M

318K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $38.4B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

Stay updated on Harding Loevner LP with notifications on news.